STAT+: Rare disease drugmakers try to avoid Trump price cuts

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. “You best step back before I bust a smack, yak!” That’s not what RFK Jr. said before fending off a shaggy beast with a phone thump to the nose, but it would’ve been cooler if he did. Send news tips and missed opportunities to [email protected] or John_Wilkerson.07 on Signal. Messaging wars: affordability vs. fraud Rising out-of-pocket health care costs remain voters’ top health priority overall, but Republicans are more worried about fraud in government health programs, according to a KFF poll. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe